Scabies: Transcutaneous Poisoning During Treatment
The FDA Drug Bulletin (6:28, 1976) alerted physicians and other health professionals to the possibility of adverse central nervous system (CNS) side effects, particularly in children, that may occur from high doses of the commonly employed scabicides. The American Academy of Pediatrics has requested its members to report adverse reactions from scabicides to the AAP, which, in turn, will keep the FDA informed.
Following the FDA Drug Bulletin alert and the announcement by the AAP, the FDA's Division of Drug Experience received the following clinical reports of suspected CNS toxicity to gamma benzene hexachloride (GBH, Kwell, Gamene, lindane).
This article has been cited by other articles:
![]() |
R. C.W. Hall and R. C.W. Hall Long-Term Psychological and Neurological Complications of Lindane Poisoning Psychosomatics, December 1, 1999; 40(6): 513 - 517. [Full Text] |
||||
![]() |
M. W. Schultz, M. Gomez, R. C. Hansen, J. Mills, A. Menter, H. Rodgers, F. N. Judson, G. Mertz, and H. H. Handsfield Comparative Study of 5% Permethrin Cream and 1% Lindane Lotion for the Treatment of Scabies Arch Dermatol, February 1, 1990; 126(2): 167 - 170. [Abstract] [PDF] |
||||
![]() |
Lindane Arch Dermatol, March 1, 1988; 124(3): 321 - 322. [Abstract] [PDF] |
||||
![]() |
S. J. Friedman Lindane Neurotoxic Reaction in Nonbullous Congenital Ichthyosiform Erythroderma Arch Dermatol, August 1, 1987; 123(8): 1056 - 1058. [Abstract] [PDF] |
||||
![]() |
J. F. DOLEZAL and J. C. PLAMONDON Neonatal Scabies Arch Pediatr Adolesc Med, October 1, 1980; 134(10): 1003 - 1003. [Abstract] [PDF] |
||||
![]() |
A. K. Pramanik and R. C. Hansen Transcutaneous Gamma Benzene Hexachloride Absorption and Toxicity in Infants and Children Arch Dermatol, October 1, 1979; 115(10): 1224 - 1225. [Abstract] [PDF] |
||||







